Offline dengan aplikasi Player FM !
Ep 4. De novo lupus nephritis and belimumab
Manage episode 326471194 series 3341497
Prof Christopher Sjöwall (Linköping, Sweden) and Dr Anastastia Madenidou discuss de novo lupus nephritis during treatment with belimumab. They cover the process of collecting observational data, the approval of belimumab for use in lupus nephritis, and implications for clinical practice.
Read the paper here: https://doi.org/10.1093/rheumatology/keaa796
Registration is open for BSR's Annual Conference. As the UK's leading rheumatology event, we bring together over 2,000 delegates for three days of learning, knowledge sharing, networking and innovation. Book your ticket today!
Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.
43 episode
Manage episode 326471194 series 3341497
Prof Christopher Sjöwall (Linköping, Sweden) and Dr Anastastia Madenidou discuss de novo lupus nephritis during treatment with belimumab. They cover the process of collecting observational data, the approval of belimumab for use in lupus nephritis, and implications for clinical practice.
Read the paper here: https://doi.org/10.1093/rheumatology/keaa796
Registration is open for BSR's Annual Conference. As the UK's leading rheumatology event, we bring together over 2,000 delegates for three days of learning, knowledge sharing, networking and innovation. Book your ticket today!
Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.
43 episode
Semua episode
×Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.